Viemed Healthcare (VMD) Return on Equity (2018 - 2025)
Viemed Healthcare's Return on Equity history spans 8 years, with the latest figure at 0.11% for Q4 2025.
- For Q4 2025, Return on Equity rose 2.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 2.0%, while the annual FY2025 figure was 0.11%, 2.0% up from the prior year.
- Return on Equity reached 0.11% in Q4 2025 per VMD's latest filing, up from 0.1% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.35% in Q1 2021 to a low of 0.06% in Q1 2023.
- Average Return on Equity over 5 years is 0.1%, with a median of 0.09% recorded in 2022.
- The largest YoY upside for Return on Equity was 12bps in 2021 against a maximum downside of -35bps in 2021.
- A 5-year view of Return on Equity shows it stood at 0.1% in 2021, then tumbled by -34bps to 0.07% in 2022, then soared by 41bps to 0.09% in 2023, then decreased by -4bps to 0.09% in 2024, then increased by 25bps to 0.11% in 2025.
- Per Business Quant, the three most recent readings for VMD's Return on Equity are 0.11% (Q4 2025), 0.1% (Q3 2025), and 0.1% (Q2 2025).